Novartis Oncology Head of Global Talent Acquisition Salaries in Wilmington, DE
The average Novartis Oncology Head of Global Talent Acquisition in Wilmington, DE earns an estimated $184,964 annually, which includes an estimated base salary of $151,303 with a $33,661 bonus. Novartis Oncology's Head of Global Talent Acquisition compensation is $20,057 more than the US average for a Head of Global Talent Acquisition. Head of Global Talent Acquisition salaries at Novartis Oncology in Wilmington, DE can range from $70,500 - $430,000.
In Wilmington, DE, The HR Department at Novartis Oncology earns $14,442 more on average than the IT Department.
Last updated 3 years ago.
- $151,303
- avg. base
- $33,661
- avg. bonus
Head of Global Talent Acquisition Salaries at Novartis Oncology
In Wilmington, DE, Heads of Global Talent Acquisition earn $1,744 more than Directors of HR.
Compensation at Novartis Oncology by Department
In Wilmington, DE, The HR Department averages $14,442 more than the IT Department, and $6,404 less than the Design Department
Head of Global Talent Acquisition Compensation by Gender (All Companies)
The average female Head of Global Talent Acquisition at companies similar size to Novartis Oncology reported making $181,208, while the average male Head of Global Talent Acquisition at similar sized companies reported making $186,115.
Head of Global Talent Acquisition Compensation by Ethnicity (All Companies)
The average African American/Black Head of Global Talent Acquisition at companies similar size to Novartis Oncology reported making $201,250, while the average Hispanic or Latino Head of Global Talent Acquisition at similar sized companies reported making $143,063.
How Heads of Global Talent Acquisition at Novartis Oncology Rate Their Compensation
The majority of Heads of Global Talent Acquisition at Novartis Oncology believe they're not compensated fairly. 100% of Heads of Global Talent Acquisition at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
